Investing.com - Milestone Pharmaceuticals (NASDAQ:MIST) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Milestone Pharmaceuticals announced earnings per share of $-0.340 on revenue of $1.5M. Analysts polled by Investing.com anticipated EPS of $-0.400 on revenue of $0.00.
Milestone Pharmaceuticals shares are down 4.96% from the beginning of the year, still down 55.21% from its 52 week high of $9.85 set on September 20.
Milestone Pharmaceuticals shares gained 7.82% in intra-day trade following the report.
Milestone Pharmaceuticals follows other major Healthcare sector earnings this month
Milestone Pharmaceuticals's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar